1. Volume 142, Issue 2, Pages 248-256 (February 2012)
Next-Generation Stool DNA Test Accurately Detects Colorectal Cancer and Large Adenomas 
David A. Ahlquist, Hongzhi Zou, Michael Domanico, Douglas W. Mahoney, Tracy C. Yab, William R. Taylor, Malinda L. Butz, Stephen N. Thibodeau, Linda Rabeneck, Lawrence F. Paszat, Kenneth W. Kinzler, Bert Vogelstein, Niels Chr. Bjerregaard, Søren Laurberg, Henrik Toft Sørensen, Barry M. Berger, Graham P. Lidgard 
Gastroenterology 
Volume 142, Issue 2, Pages (February 2012)
DOI: /j.gastro
Copyright © 2012 AGA Institute Terms and Conditions

2. Figure 1
Neoplasm detection by next-generation stool DNA test prototypes. ROC curves are shown for (A) training set and (B) test set. See Table 2 for definition of prototype test.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2012 AGA Institute Terms and Conditions

3. Figure 2
Affect of neoplasm size on stool DNA test detection rates. (A) Adenomas. Detection rates increased directly with lesion size; P < (B) Colorectal cancer. Although all 8 cancers around 1 cm in size were detected, detection rates overall increased with lesion size; P = .008.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2012 AGA Institute Terms and Conditions

4. Figure 3
Relationship of neoplasm size to quantitative stool DNA test scores: colorectal adenoma vs cancer. When stool DNA test scores were plotted against neoplasm size by piece-wise linear regression, curves for adenomas and cancers did not differ significantly; P = .40.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2012 AGA Institute Terms and Conditions

5. Figure 4
Effect of neoplasm site on detection rates by stool DNA testing. Detection rates were comparable between proximal and distal colorectal cancers (P = NS) and between proximal and distal adenomas (P = NS).
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2012 AGA Institute Terms and Conditions

6. Figure 5
Affect of colorectal cancer stage on detection rates by stool DNA testing. Detection rates did not differ significantly between stages I, II, or III. However, aggregate sensitivity of 87% for stages I–III was significantly higher than the sensitivity of 69% for stage IV; P = .02.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2012 AGA Institute Terms and Conditions